Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026)
Veracyte (VCYT) posted Non-Current Deferred Tax Liability of $636000.0 for Q1 2026, down 1.55% sequentially from $646000.0 in Q4 2025, and down 48.79% YoY from $1.2 million in Q1 2025.
Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Veracyte (VCYT) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $636000.0 in Q1 2026.
- Quarterly Non-Current Deferred Tax Liability fell 48.79% year-over-year to $636000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $636000.0 (down 48.79% YoY) and the FY2025 annual result came in at $646000.0, down 98.17% from the prior year.
- Non-Current Deferred Tax Liability eased to $636000.0 in Q1 2026 per VCYT's latest filing, from $646000.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $36.7 million in Q4 2022, with the low at $636000.0 in Q1 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $7.8 million, with a median of $3.6 million recorded in 2023.
- Year-over-year, Non-Current Deferred Tax Liability surged 564.4% in 2022 and slumped 98.17% in 2025.
- Veracyte's Non-Current Deferred Tax Liability stood at $36.7 million in 2022, then slumped by 35.65% to $23.6 million in 2023, then soared by 48.89% to $35.2 million in 2024, then plunged by 98.17% to $646000.0 in 2025, then retreated by 1.55% to $636000.0 in 2026.
- Business Quant data shows VCYT's Non-Current Deferred Tax Liability at $636000.0 in Q1 2026, $646000.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 23.65 Mn |
| Dec 31, 2023 | 23.65 Mn |